alexa
Reach Us +1-947-333-4405
New Strategies To Present An Anti-candidiasis Synthetic Glycopeptide Vaccine Acceptable For Human Use | 9813
ISSN: 2157-7560

Journal of Vaccines & Vaccination
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference on Vaccines & Vaccination

Hong Xin, Jonathan Cartmell, David R. Bundle and Jim E. Cutler
ScientificTracks Abstracts: J Vaccines Vaccin
DOI: 10.4172/2157-7560.S1.016
Abstract
Background: Our research on pathogenesis of experimental disseminated candidiasis led to the discovery that antibodies specific for Candida albicans cell surface β-1, 2-mannotriose [b-(Man)3] protect mice against the disease. Use of a 14 mer peptide Fba, which derived from the N-terminal portion of the C. albicans cell surface protein fructose-bisphosphate aldolase, as the carrier for the glycan has resulted in a novel synthetic glycopeptide vaccine b-(Man)3-Fba. This conjugate uniquely induces protective responses against both the glycan and peptide carrier parts of the vaccine in a mouse model of human disseminated candidiasis. Current work: We have isolated monoclonal antibodies (MAbs) specific for the Fba peptide. Use of these MAbs in flow cytometric and confocal microscopic analyses provide evidence that the peptide is expressed on the fungal cell surface during growth as yeast and hyphal forms. Furthermore, one of the MAbs given passively to na?ve mice protects the animals against candidiasis. We conclude that the b-(Man)3-Fba vaccine protects mice by inducing protective antibodies against both the glycan and peptide parts of the vaccine conjugate. We have now modified the b-(Man)3-Fba conjugate by coupling it to tetanus toxoid (TT) in order to improve immunogenicity and allow for use of an adjuvant suitable for human use. b-(Man)3-Fba-TT was administered alone, or as either a mixture made with alum or monophosphoryl lipid A (MPL) adjuvants by subcutaneous (s.c.) injection in mice on days 1, 21 and 62. Mice that received the conjugate vaccine prepared in either adjuvant responded as expected by making robust antibody responses. Surprisingly, mice that received the b-(Man)3-Fba-TT without adjuvant also responded well. All three groups of mice also showed protection against a lethal challenge with C. albicans as evidenced by increased median survival times and reduced kidney fungal burden as compared to control groups that received only adjuvants or DPBS buffer prior to challenge. To confirm that induced antibodies were protective, sera from mice immunized against the b-(Man)3-Fba-TT conjugate were found to transfer protection against disseminated candidiasis to na?ve mice, whereas C. albicans-adsorbed immune sera did not. Conclusion: We conclude that tetanus toxiod is a suitable secondary carrier for the glycopeptide conjugate as it induces robust antibody responses and protective immunity administered with or without adjuvants that may be suitable for human use.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

streamtajm

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version